10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER

被引：271
作者：
BONADONNA, G
VALAGUSSA, P
ROSSI, A
TANCINI, G
BRAMBILLA, C
ZAMBETTI, M
VERONESI, U
机构：
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1985年 / 5卷 / 02期
关键词：
D O I：
10.1007/BF01805984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 115
页数：21
相关论文
共 48 条
[21]   1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].
FISHER, B ;
CARBONE, P ;
ECONOMOU, SG ;
FRELICK, R ;
GLASS, A ;
LERNER, H ;
REDMOND, C ;
ZELEN, M ;
BAND, P ;
KATRYCH, DL ;
WOLMARK, N ;
FISHER, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122
[22]   PROLONGED DISEASE-FREE SURVIVAL IN HODGKINS-DISEASE WITH MOPP REINDUCTION AFTER 1ST RELAPSE [J].
FISHER, RI ;
DEVITA, VT ;
HUBBARD, SP ;
SIMON, R ;
YOUNG, RC .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) :761-763
[23]  
GLASS A, 1981, CANCER TREAT REP, V65, P363
[24]  
HOWELL A, 1984, LANCET, V2, P307
[25]  
JONES SE, 1984, ADJUVANT THERAPY CAN, V4
[26]  
Knobf M K, 1983, Oncol Nurs Forum, V10, P28
[27]  
LANGLANDS OA, 1984, INT J RAD ONCOL BIOL, V10, P943
[28]  
MARTIN DS, 1975, CANCER CHEMOTH REP 2, V5, P89
[29]  
NISSENMEYER R, 1978, CANCER, V41, P2088, DOI 10.1002/1097-0142(197806)41:6<2088::AID-CNCR2820410604>3.0.CO
[30]  
2-J
12345